Glypican 2 As A Cancer Marker And Therapeutic Target
Hungary
16864859.0
Filed on 2018-05-18
16864859.0
Filed on 2018-05-18
Glypican 2 As A Cancer Marker And Therapeutic Target
Spain
16864859.0
Filed on 2018-05-18
16864859.0
Filed on 2018-05-18
PREDICTING PATIENT RESPONSE TO CANCER THERAPY VIA HISTOPATHOLOGY IMAGES
US Application 18/868,028
Filed on 2024-11-21
Filed on 2024-11-21
METHODS FOR PRODUCING AUTOLOGOUS T CELLS USEFUL TO TREAT B CELL MALIGNANCIES AND OTHER CANCERS AND COMPOSITIONS THEREOF
Serbia
15746399.3
Filed on 2015-02-04
15746399.3
Filed on 2015-02-04
METHODS FOR PRODUCING AUTOLOGOUS T CELLS USEFUL TO TREAT B CELL MALIGNANCIES AND OTHER CANCERS AND COMPOSITIONS THEREOF
San Marino
15746399.3
Filed on 2015-02-04
15746399.3
Filed on 2015-02-04
METHODS FOR PRODUCING AUTOLOGOUS T CELLS USEFUL TO TREAT B CELL MALIGNANCIES AND OTHER CANCERS AND COMPOSITIONS THEREOF
Liechtenstein
15746399.3
Filed on 2015-02-04
15746399.3
Filed on 2015-02-04
METHODS FOR PRODUCING AUTOLOGOUS T CELLS USEFUL TO TREAT B CELL MALIGNANCIES AND OTHER CANCERS AND COMPOSITIONS THEREOF
Malta
15746399.3
Filed on 2015-02-04
15746399.3
Filed on 2015-02-04
METHODS FOR PRODUCING AUTOLOGOUS T CELLS USEFUL TO TREAT B CELL MALIGNANCIES AND OTHER CANCERS AND COMPOSITIONS THEREOF
North Macedonia
15746399.3
Filed on 2015-02-04
15746399.3
Filed on 2015-02-04
METHODS FOR PRODUCING AUTOLOGOUS T CELLS USEFUL TO TREAT B CELL MALIGNANCIES AND OTHER CANCERS AND COMPOSITIONS THEREOF
Monaco
15746399.3
Filed on 2015-02-04
15746399.3
Filed on 2015-02-04